tirzepatide removed from shortage list In October 2024, the FDA reported that the (Mounjaro, Zepbound) injection was over. If you had trouble accessing these medications or had to rely on compounded versions, this is how FDA Shortage and Semaglutide &
Description
A new option called orforglipron, a nonpeptide oral GLP-1, may be available in 2026

What disappeared was something very specific: the excitement of finding the next great meal

Clinical trials demonstrate the transformative potential of Wegovy, with users shedding an average of 14.9% to 17.4% of their initial body weight over 68 weeks

However, rapid weight loss may temporarily affect: Hormone levels : Fat tissue produces oestrogen, and substantial fat loss can alter sex hormone balance

It's a tiny syringe that most people barely feel